blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3865123

EP3865123 - LIPID-DERIVED NEUTRAL NANOPARTICLES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  18.02.2022
Database last updated on 22.08.2024
FormerThe application has been published
Status updated on  16.07.2021
Most recent event   Tooltip03.01.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Translate Bio, Inc.
200 West Street
Waltham, MA 02451 / US
[2022/25]
Former [2021/33]For all designated states
Translate Bio, Inc.
29 Hartwell Avenue
Lexington, MA 02421 / US
Inventor(s)01 / DEROSA, Frank
26 Mt. Auburn Street
Chelmsford, MA 01824 / US
02 / GUILD, Braydon, Charles
109 Riverside Road
Concord, MA 01742 / US
03 / HEARTLEIN, Michael
167 Reed Farm Road
Boxborough, MA 01719 / US
 [2021/33]
Representative(s)Lavoix
2, place d'Estienne d'Orves
75441 Paris Cedex 09 / FR
[N/P]
Former [2021/33]Goodfellow, Hugh Robin
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
Application number, filing date20214617.129.03.2013
[2021/33]
Priority number, dateUS201261617478P29.03.2012         Original published format: US 201261617478 P
[2021/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3865123
Date:18.08.2021
Language:EN
[2021/33]
Search report(s)(Supplementary) European search report - dispatched on:EP19.07.2021
ClassificationIPC:A61K9/127, C12N15/11, C12N15/88, G01N33/92, A61K38/44
[2021/33]
CPC:
A61K9/1277 (EP,US); A61K38/44 (EP,US); A61K47/28 (US);
A61K9/1271 (EP,US); A61K9/1272 (EP,US); C12N15/111 (EP,US);
A61K48/00 (US); C12N2310/11 (EP,US); C12N2310/14 (EP,US);
C12N2310/141 (EP,US); C12N2310/16 (EP,US); C12N2310/3515 (EP,US);
C12N2320/32 (EP,US); C12Y113/12007 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/12]
Former [2021/33]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
TitleGerman:AUS LIPIDEN GEWONNENE NEUTRALE NANOPARTIKEL[2021/33]
English:LIPID-DERIVED NEUTRAL NANOPARTICLES[2021/33]
French:NANOPARTICULES NEUTRES DÉRIVÉES DE LIPIDES[2021/33]
Examination procedure11.02.2022Amendment by applicant (claims and/or description)
11.02.2022Examination requested  [2022/12]
11.02.2022Date on which the examining division has become responsible
Parent application(s)   TooltipEP13769005.3  / EP2830596
Fees paidRenewal fee
16.12.2020Renewal fee patent year 03
16.12.2020Renewal fee patent year 04
16.12.2020Renewal fee patent year 05
16.12.2020Renewal fee patent year 06
16.12.2020Renewal fee patent year 07
16.12.2020Renewal fee patent year 08
09.03.2021Renewal fee patent year 09
16.03.2022Renewal fee patent year 10
14.02.2023Renewal fee patent year 11
03.01.2024Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US5965434  (WOLFF JON A [US], et al) [A] 1-15 * abstract * * columns 12-14 *;
 [XP]WO2012170889  (SHIRE HUMAN GENETIC THERAPIES [US], et al) [XP] 1-9,15 * abstract ** claims 1-38, 50-56 *;
 [A]  - TANG ET AL, "Introduction of a Disulfide Bond into a Cationic Lipid Enhances Transgene Expression of Plasmid DNA", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (19980106), vol. 242, no. 1, doi:10.1006/BBRC.1997.7923, ISSN 0006-291X, pages 141 - 145, XP005100898 [A] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1006/bbrc.1997.7923
 [A]  - WETZER B ET AL, "Reducible cationic lipids for gene transfer", BIOCHEMICAL JOURNAL, PORTLAND PRESS LTD, GB, (20010615), vol. 356, no. Pt 3, doi:10.1042/0264-6021:3560747, ISSN 0264-6021, pages 747 - 756, XP002407694 [A] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1042/0264-6021:3560747
by applicantUS4737323
 US4897355
 US4946683
 US5171678
 US5334761
 US5744335
 US5885613
 WO2005121348
 WO2007031091
    - LI et al., Pharm Res., (20070000), vol. 24, pages 438 - 449
    - SHERWOOD, R.F., Adv. Drug Del. Rev., (19960000), vol. 22, pages 269 - 288
    - TOKI et al., J. Org. Chem., (20020000), vol. 67, pages 1866 - 1872
    - YONEDA et al., Bioorg. Med. Chem. Lett., (20080000), vol. 18, pages 1632 - 1636
    - NORI et al., Bioconj. Chem., (20030000), vol. 14, pages 44 - 50
    - VERONESE et al., Bioconj. Chem, (20050000), vol. 16, pages 775 - 784
    - DENARDO et al., Clin. Canc. Res., (20030000), vol. 9, pages 3665s - 3972s
    - CHAU et al., J. Pharm. Sci., (20060000), vol. 95, pages 542 - 551
    - STERN et al., Bioconj. Chem., (20090000), vol. 20, pages 500 - 510
    - CHRISTENSEN et al., Nucl. Acids. Res., (20020000), vol. 30, pages 4918 - 4925
    - NG et al., Nature Genetics, (20100000), vol. 42, pages 1035 - 1036
    - KOZAK, M., Nucleic Acids Res, (19870000), vol. 15, no. 20, pages 8125 - 48
    - HEIDENREICH et al., J Biol Chem, (19940000), vol. 269, pages 2131 - 8
    - KARIKO, K. et al., Molecular Therapy, (20080000), vol. 16, no. 11, pages 1833 - 1840
    - YOKOE et al., Nature Biotechnology, (19960000), vol. 14, pages 1252 - 1256
    - GAO et al., Biochem. Biophys. Res. Comm., (19910000), vol. 179, page 280
    - FELGNER et al., Proc. Nat'l Acad. Sci., (19870000), vol. 84, page 7413
    - BEHR et al., Proc. Nat.'l Acad. Sci., (19890000), vol. 86, page 6982
    - HEYES, J. et al., J Controlled Release, (20050000), vol. 107, pages 276 - 287
    - MORRISSEY, DV. et al., Nat. Biotechnol., (20050000), vol. 23, no. 8, pages 1003 - 1007
    - WOLF et al., BioTechniques, (19970000), vol. 23, page 139
    - KLIBANOV et al., FEBS Letters, (19900000), vol. 268, no. 1, pages 235 - 237
    - N.J. CAPLEN et al., Gene Ther, (19950000), vol. 2, page 603
    - S. LI et al., Gene Ther, (19970000), vol. 4, page 891
    - LASIC et al., FEBS Lett., (19920000), vol. 312, pages 255 - 258
    - "Reduction of Liposome Size and Preparation of Unilamellar Vesicles by Extrusion Techniques", HOPE, M J et al., Liposome Technology, (19930000), vol. 1, page 123
    - BLOOMFIELD, Ann. Rev. Biophys. Bioeng., (19810000), vol. 10, pages 421 - 450
    - PONSA et al., Int. J. Pharm., (19930000), vol. 95, pages 51 - 56
    - FECHTER, P. et al., J. Gen. Virology, (20050000), vol. 86, pages 1239 - 1249
 US19450614947
 US19810614948
 US20140614947
 US19820614948
 WO2010US58457
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.